“If you get through the first two years of this experience and feel like you have a future and have a sense of personhood, and you can be somebody—what a difference,” said OnTrackNY's Dr. Lisa Dixon.
Adrian Jacques Ambrose, MD, MPH, FAPA, medical director of the Columbia Psychiatry Faculty Practice Organization, discusses the newest research into the neuroscience of anxiety and depression.
At Columbia Cohen Center for Health and Recovery from Tick-borne diseases, Kristen Kendrick takes the time to assess the patient from multiple perspectives.
Chacku Mathai, a project director with OnTrackNY, thinks about whether, if the perfect antipsychotic existed, he would take it. “My experience is so rich,” he said, “I wouldn’t trade it for anything.”
"There's no way that these drugs can meet the fantasized expectations that people have,” David Hellerstein, MD, a professor of clinical psychiatry at Columbia, said in reference to psychedelics.
Melina Wald, director of the Gender Identity Program at Columbia, says that waiting to transition can create additional psychological distress for a child.
“Ketamine is a medical treatment intended to address a significant illness,” such as severe depression or suicidal ideation, said Joshua Berman, assistant professor of psychiatry at Columbia.